期刊文献+

聚合酶链反应单链构象多态性和银染技术筛查胰岛素受体基因突变 被引量:4

PCR SSCP and silver staining technique in screening insulin receptor gene mutation
原文传递
导出
摘要 目的建立聚合酶链反应单链构象多态性(RCRSSCP)和银染技术筛查胰岛素受体基因突变方法。方法选择89例非胰岛素依赖型糖尿病患者,PCR扩增编码胰岛素受体酪氨酸激酶域的外显子(外显子17~21),进行SSCP电泳,银染色后,对突变样品进行序列分析。结果发现11例外显子17和1例外显子20的异常电泳条带,外显子17的突变经顺序分析,为CAC1058→CAT1058的杂合和纯合多态性突变。结论PCRSSCP结合银染技术是一种操作简便、经济、灵敏度高、适合于临床大样本基因突变筛查的方法。 Objective To establish polymerase chain reaction single strand conformation polymorphism(PCR SSCP) and silver staining technique to screen mutation of insulin receptor gene. Methods 89 patients with NIDDM were collected.Exon 17 21 of insulin receptor gene were amplified by PCR and screened by SSCP electrophoresis.After silver staining,the mutation samples was sequenced.Resulets Eleven variant sequences in exon 17 and 1 in exon 20 were detected. Direct sequence analysis of exon 17 showed that homozygous and heterozygous nonsense mutations were silent polymorphism at position 1058 (CAC→CAT).Conclusion The PCR SSCP combining with silver staining technique is simple, economic, and sensitive.
出处 《中华医学检验杂志》 CSCD 1999年第2期87-89,共3页
关键词 糖尿病 受体 胰岛素 单链构象多态性 银染法 Polymorphism, single stranded conformational Receptors, insulin Mutation Polymerase chain reaction
  • 相关文献

同被引文献16

  • 1张铁军,周晓明,姜庆五.淋病奈瑟氏菌对环丙沙星耐药性与喹诺酮类耐药决定区突变的关系[J].疾病控制杂志,2005,9(6):600-603. 被引量:4
  • 2邹炼,韩骅,宋海燕,于茂生,邵国兴.ras癌基因点突变与膀胱癌关系的研究[J].中华泌尿外科杂志,1996,17(4):216-218. 被引量:3
  • 3WHO Western Pacific Gonococcal Antimicrobial Surveillance Programme. Surveillance of antibiotic resistance in Neisseria gonorrhoeae in the WHO Health Organization Western Pacific Region,2003 [J]. Commun Dis Intell, 2005,29(1):62-64.
  • 4Ison CA, Wcodford PJ, Madders H, et al. Drift in susceptibility of neisseria gonorrhoeae to ciprofloxacin and emergence of therapeutic failure [J]. Antimicrob Agents Chemother, 1998,42(11):2919-2922.
  • 5Yong D, Kim TS, Choi JR, et al. Epidemiological characteristics and molecular basis of fluoroquinolone-resistant Neisseria gonor-rhoeae strains isolated in Korea and nearby countries [J]. J Antimicrob Chemother, 2004,54(2):451-455.
  • 6NCCLS. Performance Standards for Antimicrobial Susceptibility Testing: Fifteenth Informational Supplement [J]. M100-S15,2005,25:60-62.
  • 7Deguchi T, Yasuda M, Nakano M, et al. Rapid detection of point mutations of the Neisseria gonorrhoeae gyrA gene associated with decreased susceptibilities to quinolones [J]. J Clin Microbiol, 1996,34 (9): 2255-2258.
  • 8Shigemura K, Shirakawa T, Okada H, et al. Mutations in the gyrA and parC genes and in vitro activities of fluoroquinolones in 91 clinical isolates of Neisseria gonorrhoeae in Japan [J]. Sex Transm Dis, 2004,31(3): 180-184.
  • 9Tanaka M, Nakayama H, Haraoka M, et al. Susceptibilities of Neisseria gonorrhoeae isolates containing amino acid substitutions in GyrA, with or without substitutions in ParC, to newer fluoro-quinolones and other antibiotics [J]. Antimicrob Agents Chemothera, 2000,44(1): 192-195.
  • 10Chaudhry U, Ray K, Bala M, et al. Mutation patterns in gyrA and parC genes of ciprofloxacin resistant isolates of Neisseria gonorrhoeae from India [J]. Sex Transm Infect, 2002,78(6):440-444.

引证文献4

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部